Uncategorized

Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20% – CNBC

Posted on Author Tim Hodges Comments Off on Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20% – CNBC
  1. Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%  CNBC
  2. Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing  Yahoo Finance
  3. Novo Nordisk ends collaboration with Hims & Hers over weight loss drug sale  Reuters
  4. Novo Exits Hims & Hers Partnership, Citing Compounding Concerns  Bloomberg.com
  5. Novo Nordisk ends deal with Hims due to compounding concerns with obesity drugs  STAT